Publication | Closed Access

Therapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemia

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyTherapeutic ApplicationSmall RnaRadiation OncologyMolecular DiagnosticsCell BiologyCancer ResearchBcr-abl TranscriptsMyeloid Neoplasia